Hilhorst, V. J., Bruninx, A., Bermejo, I., Gonzalvo, C. M., Magdelijns, F. J. H., Faber, C. G., & Karapinar-Carkit, F. (2026). Clinical impact of medication reconciliation on physicians’ treatment policies at outpatient clinics: a cross-sectional study. BMC Health Services Research, 26(1), Article 1360. https://doi.org/10.1186/s12913-026-15021-z

Kruithof, P. D., Dontje, A. E. W. K., Salmans, M. M. A., Winckers, K., van Geffen, W. H., Hendriks, L. E. L., Croes, S., ter Heine, R., & van Geel, R. (2026). Exploring therapeutic drug monitoring-guided direct oral anticoagulant use in patients with non-small cell lung cancer treated with small-molecule inhibitors. Thrombosis Update, 25, Article 100253. https://doi.org/10.1016/j.tru.2026.100253

Januzzi, J. L., Gibson, C. M., Chi, G., Coller, B. S., Granger, C. B., Montalescot, G., Rikken, S. A. O. F., Verburg, A., Berg, J. M. T., & van 't Hof, A. W. J. (2026). The effect of zalunfiban on high sensitivity cardiac troponin and the association with clinical outcomes in patients with STEMI. American Heart Journal, 301, Article 107513. https://doi.org/10.1016/j.ahj.2026.107513

Shaw, J. R., Burger, D., Vassart, J., Hardy, M., Castellucci, L. A., Carrier, M., Kim, P. Y., Douxfils, J., Mullier, F., Rocca, B., Connors, J. M., Spronk, H., Levy, J. H., & ten Cate, H. (2026). Thrombin generation and the pharmacodynamics of oral anticoagulants. Pharmacology & Therapeutics, 287, Article 109102. https://doi.org/10.1016/j.pharmthera.2026.109102

Kempers, E. K., Acampo-de Jong, M. J. J., ten Cate, H., De Caterina, R., & Kruip, M. J. H. A. (2026). Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice. Heart, 112(22), 1237-1247. https://doi.org/10.1136/heartjnl-2024-324551

Broeze, G. M., Aarts, H. M., Voorham, J. D. S., Hemelrijk, K. I., van Ginkel, D. J., Versteeg, G. A. A., Grundeken, M. J., Claessen, B. E. P. M., Tonino, P. A. L., Schotborgh, C. E., Meuwissen, M., van Houwelingen, G. K., Wykrzykowska, J. J., Amoroso, G., Vossenberg, T. N., Vriesendorp, P. A., van Royen, N., ten Berg, J. M., Tijssen, J. G. P., ... PRO TAVI Investigators (2026). Impact of Extent of Coronary Artery Disease in Transcatheter Aortic Valve Replacement A PRO-TAVI Substudy. Jacc-Cardiovascular Interventions, 19(19), 2619-2630. https://doi.org/10.1016/j.jcin.2026.07.034

Azzahhafi, J., Chan Pin Yin, D. R. P. P., van der Sangen, N. M. R., van den Broek, W. W. A., Sivanesan, S., van de Pol, Q. Y. F., Walhout, R. J., Gin, M. T. J., Pisters, R., Nicastia, D. M., Langerveld, J., Vlachojannis, G. J., van Bommel, R. J., Appelman, Y., Henriques, J. P. S., Kikkert, W. J., & ten Berg, J. M. (2026). Average daily ischaemic and bleeding risk following acute coronary syndrome: insights from the FORCE-ACS registry. European Heart Journal-Cardiovascular Pharmacotherapy. Advance online publication. https://doi.org/10.1093/ehjcvp/pvag084

Nieuwenstein, T., Stoffer, I. P., Hellenbrand, D. L. S., Mathot, R. A. A., van Pelt, L. J., Pequeriaux, N. C. V., van de Kerkhof, D., Kuijper, P. H. M., Zant, J. C., Garnier, D. A. J., Schindhelm, R. K., Hamer, H. M., van Duijnhoven, H. L. P., Bosman, M. C. J., Jeninga, E. H., de Kok, J. B., Schellings, M. W. M., Waals-Prinzen, L., Rijpma, S. R., ... Stroobants, A. K. (2026). Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays. Clinical Chemistry and Laboratory Medicine, 64(11), 2590-2601. https://doi.org/10.1515/cclm-2026-0026

Valanciene, J., Ylikotila, P., Lautamäki, R., Zedde, M., Grimaldi, T., Sarkanen, T., Ryödi, E., Jatužis, D., Ryliškiene, K., Zakarkaite, D., von Sarnowski, B., Busch, R., Tulkki, L., Pirinen, J., Martinez-Majander, N., Licenik, R., Ferdinand, P., Oxley, C., Kõrv, J., ... SECRETO Study Group Investigators (2026). Association Between Recent Mechanical Risk Factors for Venous Thrombosis and Young-Onset Cryptogenic Ischemic Stroke. Stroke, 57(10), 3010-3023. https://doi.org/10.1161/STROKEAHA.125.054299

Baaten, C. C. F. M. J. (2026). Casting Light on the Regulation of Platelet Reactivity by Calcitriol. JACC: Basic to Translational Science, 11(10), Article 101702. https://doi.org/10.1016/j.jacbts.2026.101702

van der Walle, K., Denig, P., Boerman, T., Magdelijns, F. J. H., Nielen, J. T. H., & Karapinar-Carkit, F. (2026). Creating Awareness of preScribing Cascades and Managing Adverse Drug Effects (CASC-ADE) Tool: Appraisal by Future End Users. Drugs & Aging, 43(10), 933-943. https://doi.org/10.1007/s40266-026-01334-5

Willems, R. A. L., Graus, M. U. J. E., van Gansewinkel, E. H. E., van Diepen, A. E., Cirkel, G. A., van Laarhoven, H. W. M., Wumkes, M. L., Homs, M. Y. V., Wilmink, J. W., Klok, F. A., van Es, N., ten Cate, H., de Vos-Geelen, J., & Dutch Pancreatic Cancer Group (2026). Prevention of Venous Thromboembolism in Patients With Pancreatic Cancer: A Nationwide Survey. Cancer Medicine, 15(10), Article e72306. https://doi.org/10.1002/cam4.72306

Rocca, B., & Ten Cate, H. (2026). Antidotes for Anticoagulation Reversal. Reply. New England Journal of Medicine, 395(11), 1144. https://doi.org/10.1056/NEJMc2609248

Galli, M., Capodanno, D., Berg, J. T., Cavallari, L. H., Rao, S. V., Lemos, P. A., Valgimigli, M., Gaudino, M., Kastrati, A., Steg, P. G., Lopes, R. D., Gibson, C. M., Mehran, R., & Angiolillo, D. J. (2026). Aspirin Withdrawal in Patients With Coronary Artery Disease. Journal of the American College of Cardiology, 88(11), 1232-1254. https://doi.org/10.1016/j.jacc.2026.06.003

Willems, R. A. L., De Simone, I., Tufaha, S., Konings, J., Middelveld, H., Pepels-Aarts, N., Ten Cate, H., De Laat, B., Roest, M., Huskens, D., & de Vos-Geelen, J. (2026). Plasmin Generation Kinetics Reveal a Hyperfibrinolytic Phenotype in Patients with Pancreatic Ductal Adenocarcinoma. TH open : companion journal to thrombosis and haemostasis, 10, Article a29256824. https://doi.org/10.1055/a-2925-6824

Verburg, A., Linz, D., Mohaissen, T., & Ten Berg, J. (2026). Atrial fibrillation and coronary artery disease: interactions, outcomes and evolving management strategies. Heart. https://doi.org/10.1136/heartjnl-2026-328218

de Jong, M. J., Hellenbrand, D. L. S., Braeken, D. C. W., ten Cate, H., Stroobants, A. K., Henskens, Y. M. C., Magdelijns, F. J. H., & Winckers, K. (2026). Detection of abnormally high DOAC plasma concentrations using PT/INR in three different reagents in frail older patients: the DOAC-FRAIL study. Thrombosis Update, 24, Article 100250. https://doi.org/10.1016/j.tru.2026.100250

Vondenhoff, S., Antwerpen, A., Junho, C. V. C., Martin, P., Hourtz, S., Zou, J., Kurt, B., Haas, C., Fleig, S., Schulte, C., Lauxen, J., Wessiepe, M., Späte-Schulze, U., Kramann, R., Floege, J., Soehnlein, O., Jankowski, J., Goettsch, C., Döring, Y., ... Noels, H. (2026). Immature Neutrophil Phenotype and Enhanced Myeloperoxidase in Male Patients With Chronic Kidney Disease and Cardiovascular Comorbidity. Acta Physiologica, 242(9), Article e70290. https://doi.org/10.1111/apha.70290

Willems, R. A. L., Zanetto, A., Campello, E., Konings, J., Bulato, C., Kramer, M., Russo, F. P., Roest, M., Senzolo, M., Burra, P., ten Cate, H., de Vos-Geelen, J., de Laat, B., Simioni, P., & de Laat-Kremers, R. (2026). Thrombin dynamics and clinical events in cirrhosis: low prothrombin conversion predicts bleeding risk. Frontiers in Cell and Developmental Biology, 14, Article 1764080. https://doi.org/10.3389/fcell.2026.1764080

Wang, S. J., Deneer, R., Schoenmakers, T., Mestrum, S. G. C., Henskens, Y. M. C., Bekers, O., Hopman, A. H. N., Ramaekers, F. C. S., & Leers, M. P. G. (2026). A Robust Computational Workflow Utilizing Generalized Least Squares (GLS) and Generalized Estimating Equations (GEE-GLM) for Longitudinal Flow Cytometry Maturation Data Analysis. Cytometry Part A, 109(9), 664-673. https://doi.org/10.1002/cyto.a.70061

Wu, Y., & ten Cate, H. (2026). Shiver me timbers: cold-driven lipids fuel platelet production. Cell Research, 36(9), 641-642. https://doi.org/10.1038/s41422-026-01265-1

Wang, S. J., van Meel, R. A. J. N., Mestrum, S. G. C., Habets, T. H. P. M., Hopman, A. H. N., Ramaekers, F. C. S., Henskens, Y. M. C., Bekers, O., & Leers, M. P. G. (2026). Functional Characterization of Myelodysplastic Syndrome by Multiparameter Flow Cytometry: The Clinical Synergy Between Ki-67 and Bcl-2 and Their Potential Role in Diagnostics and Personalized Therapy. Cancers, 18(16), Article 2648. https://doi.org/10.3390/cancers18162648

Peeters, D. A. M., Woelders, E. C. I., Janssen, S., Azzahhafi, J., Yin, D. R. P. P. C. P., van den Broek, W. W. A., Winkler, P. J. C., van de Pol, Q. Y. F., Cetinyurek-Yavuz, A., Damman, P., Luijkx, J. J. P., Remkes, W. S., van't Hof, A. W. J., ten Berg, J. M., & van Geuns, R. J. M. (2026). Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients. IJC Heart and Vasculature, 65, Article 101961. https://doi.org/10.1016/j.ijcha.2026.101961

Chiarito, M., Mehran, R., Gibson, M. C., Cannon, C. P., Lopes, R. D., Sartori, S., Oliva, A., Smith, K., Feng, Y., Lampert, J., Goette, A., Kastrati, A., Owen, R., ten Berg, J. M., Verheugt, F. W. A., Vranckx, P., Valgimigli, M., Bhatt, D. L., Alexander, J., & Pocock, S. (2026). Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysis. European Heart Journal. Advance online publication. https://doi.org/10.1093/eurheartj/ehag740

Mussert, C. M. A., Derikx, F., Monard, A. L. L., Brandt, B., Tegels, S. H. J., Merry, I., van Doorn, W. P. T. M., Nieuwenhuizen, L., Cnossen, M. H., Henskens, Y. M. C., Beckers, E. A. M., & Heubel-Moenen, F. C. J. I. (2026). Heavy menstrual bleeding in women with a bleeding disorder of unknown cause: a common symptom impacting daily life functioning. Research and practice in thrombosis and haemostasis, 10(6), Article 106950. https://doi.org/10.1016/j.rpth.2026.106950

Caso, V., ten Cate, H., & van Gelder, I. C. (2026). The OCEANIC trial journey: from failure to breakthrough? European Heart Journal-Cardiovascular Pharmacotherapy, 12(5), 349-352. https://doi.org/10.1093/ehjcvp/pvag047

Bondi, E., Obino, G., Guidotti, G., Sensini, A., Nagy, M., Spronk, H. M. H., van Griensven, M., Lepedda, A. J., Lotti, N., & Moroni, L. (2026). Aromatic Copolyesters Based on Poly(butylene furanoate) and Poly(butylene isophthalate) for Small-Diameter Vascular Applications. ACS Biomaterial Science and Engineering, 12(7), 3557-3568. https://doi.org/10.1021/acsbiomaterials.6c00106

Stroobants, A. K., Gottgens, E.-L., Henskens, Y. M. C., Jansen, J. H., Schols, S. E. M., & Rijpma, S. R. (2026). Monitoring Extended Half-Life Factor VIII and IX Concentrates: Performance in Routine Clotting-and Thrombin Generation Assays. Haemophilia, 32(4), 1002-1015. https://doi.org/10.1111/hae.70300

van Dam, A. D., Bioch, M. M., Jeninga, E. H., de Kok, J. B., Rijpma, S. R., Thelen, M. H. M., Henskens, Y. M. C., van Oerle, R. G. M., Stroobants, A. K., & Coagulation Section of the Dutch Foundation for Quality Assessment in Medical Laboratory Diagnostics (SKML) (2026). Pre-analytical storage and reagent-dependent sensitivity as sources of variability in prothrombin time and activated partial thromboplastin time measurements. Thrombosis Research, 263, Article 109771. https://doi.org/10.1016/j.thromres.2026.109771

Simonsson, M., James, S., ten Berg, J. M., & Gigante, B. (2026). The evolution of dual antiplatelet therapy in patients with coronary artery disease. European heart journal open, 6(4), Article oeag107. https://doi.org/10.1093/ehjopen/oeag107

Derikx, F., Merry, I., Willemsen, D., Beckers, E., Henskens, Y., & Heubel-Moenen, F. (2026). A Rare Combination of von Willebrand Disease Type 2A and 2M: Diagnostic and Therapeutic Challenges – A case report. Research and practice in thrombosis and haemostasis, 10(5), Article 106867. https://doi.org/10.1016/j.rpth.2026.106867

Galli, M., Simeone, B., ten Berg, J., Capodanno, D., Valgimigli, M., Sciarretta, S., Greco, E., Kastrati, A., Montalescot, G., Gibson, C. M., Gorog, D. A., Mehran, R., & Angiolillo, D. J. (2026). Managing bleeds on anticoagulant therapy: a practical guide for clinicians. European Heart Journal: Acute Cardiovascular Care, 15(7), 557-572. Article zuag035. https://doi.org/10.1093/ehjacc/zuag035

Franssen, I. S., de Jong, M. J., Visseren, L., Teerds, D., Hellenbrand, D., Henskens, Y., Spronk, H., Janssen, D. J. A., Braeken, D. C. W., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). The DOAC-FRAIL Study-Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents. Journal of the American Geriatrics Society. Advance online publication. https://doi.org/10.1111/jgs.70559

Erdoes, G., Koster, A., Shore-Lesserson, L., Vilnits, Y., Steiner, M. E., ten Cate, H., & Mazzeffi, M. (2026). The Year in Coagulation and Transfusion: Selected Highlights. Journal of Cardiothoracic and Vascular Anesthesia, 40(7), 1939-1945. https://doi.org/10.1053/j.jvca.2026.03.005

Gorog, D. A., Ten Berg, J. M., Campo, G., Geisler, T., Gigante, B., Grove, E. L., Halvorsen, S., Huber, K., Jeong, Y. H., Lip, G. Y. H., Navarese, E. P., Rubboli, A., Siller Matula, J. M., Storey, R. F., Valgimigli, M., Vandenbriele, C., Vilahur, G., Ahrens, I., & Ferreiro, J. L. (2026). Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. Eurointervention, 22(12), e653-e677. https://doi.org/10.4244/EIJ-E-26-00003

Rocca, B., & ten Cate, H. (2026). Antidotes for Anticoagulation Reversal. New England Journal of Medicine, 394(22), 2235-2254. https://doi.org/10.1056/NEJMra2506021

Schellens, J., Nagy, M., Hulshof, A. M., van Rosmalen, F., van Oerle, R., van Herpt, T. T. W., Alnima, T., Mulder, M. M. G., Hellenbrand, D., ten Cate, H., Driessen, R. G. H., Sels, J. W. E. M., van der Horst, I. C. C., Henskens, Y. M. C., van Bussel, B. C. T., Spronk, H. M. H., & Dutch Covid and Thrombosis Coalition (2026). Inhibition of inflammation reduces hypofibrinolysis in severe COVID-19: A nested case-control study within the MaastrICCht cohort. Thrombosis Research, 262, Article 109723. https://doi.org/10.1016/j.thromres.2026.109723

Cavallari, L. H., Lee, C. R., Beitelshees, A. L., Luzum, J. A., Stouffer, G. A., ten Berg, J. M., van den Broek, W. W. A., Pereira, N. L., Sibbing, D., & Angiolillo, D. J. (2026). 2025 Acute Coronary Syndrome Guideline: Missing the Boat on CYP2C19 Genotyping. Journal of the American Heart Association, 15(10), 1-5. Article e047768. https://doi.org/10.1161/JAHA.125.047768

Galli, M., Pereira, N. L., ten Berg, J., & Angiolillo, D. J. (2026). REPLY: Genotype-Guided vs Conventional Oral P2Y₁₂ Inhibitors in Acute Coronary Syndrome. JACC. Cardiovascular interventions, 19(9), 1193-1193. https://doi.org/10.1016/j.jcin.2026.03.011

Bova, R., Bastings, J., Betti, M., Snik, C., Heuts, S., Segers, P., Winkler, P. J. C., Vriesendorp, P. A., Bidar, E., ten Berg, J. M., Lux, A., van't Hof, A. W. J., & COMMIT LAD Investigators (2026). Design and Rationale of the COMMIT-LAD Registry: A Comprehensive Analysis of Medical and Invasive Treatment Strategies for Patients With Significant Left Anterior Descending Artery Disease (COMMIT-LAD). Journal of Cardiovascular Pharmacology, 87(5), 357-363. https://doi.org/10.1097/FJC.0000000000001799

Hamulyák, E. N., Wang, T. F., Kreuziger, L. B., Iyengar, V., Carney, B. J., Hoeben, A., Özdemir, B. C., Cordova Serrano, R. D., Sanfilippo, K. M., Rozenblatt, S., Beenen, L. F. M., Yust-Katz, S., Halperin, E., Arad, A., Lubetsky, A., Carrier, M., Massat, B., Büller, H. R., Spectre, G., ... ABC Study Group (2026). Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation. Blood Vessels, Thrombosis & Hemostasis, 3(2), Article 100140. https://doi.org/10.1016/j.bvth.2026.100140

Urlings, E. H., Heubel-Moenen, F. C. J. I., van Oerle, R., Hellenbrand, D. L. S., van der Meijden, P. E. J., Hackeng, T. M., Cate, H. T., Nagy, M., Henskens, Y. M. C., & Spronk, H. M. H. (2026). Intrinsic activated thrombin generation for treatment efficacy and monitoring of octocog alfa and emicizumab in severe hemophilia A. Research and practice in thrombosis and haemostasis, 10(4), Article 106627. https://doi.org/10.1016/j.rpth.2026.106627

Azzahhafi, J., Yin, D. R. P. P. C. P., Epping, M., Bofarid, H., Verhagen, T., Boomars, R., Radstok, A., Houtgraaf, J., van Hout, G. P. J., Bikker, A., & ten Berg, J. M. (2026). Performance of the HEART Score in pre-hospital settings for suspected non-ST-elevation acute coronary syndrome: The POPular HEART Study. Netherlands Heart Journal, 34(5), 179-188. https://doi.org/10.1007/s12471-026-02041-x

Shaw, J. R., Maier, C. L., Hardy, M., Mullier, F., Douxfils, J., Tanaka, K., Rocca, B., ten Cate, H., Kim, P. Y., Carrier, M., Connors, J. M., & Levy, J. H. (2026). Thrombin generation and the pharmacodynamics of parenteral anticoagulants. Pharmacological Reviews, 78(3), Article 100135. https://doi.org/10.1016/j.pharmr.2026.100135

Abels, S., Sihvo, M., Tomppo, L., Kutal, S., Martinez-Majander, N., Tulkki, L., Sarkanen, T., Jakala, P., Redfors, P., Huhtakangas, J., Ylikotila, P., von Sarnowski, B., Yesilot, N., Waje-Andreassen, U., Fonseca, A. C., Martinez Sanchez, P., Korv, J., Ferdinand, P., Ryliskiene, K., ... Putaala, J. (2026). Thrombophilia Screening in Young Patients With Cryptogenic Ischemic Stroke. Stroke, 57(5), 1242-1255. https://doi.org/10.1161/STROKEAHA.125.053251

Magdelijns, F. J. H., de Jong, M. J., Winckers, K., Brys, A. D. H., Braeken, D. C. W., van Kuijk, S. M. J., Spronk, H. M. H., Bosman, H., Janssen, D. J. A., van Geel, R. M. J. M., Hellenbrand, D., ten Cate, H., & Henskens, Y. (2026). Assessing the efficacy of a single-cycle measurement and adjustment strategy for direct oral anticoagulants in frail older patients: rationale and design of the DOAC-FRAIL randomized controlled trial. Research and practice in thrombosis and haemostasis, 10(4), Article 106800. https://doi.org/10.1016/j.rpth.2026.106800

Delewi, R., Aarts, H. M., Broeze, G. M., Hemelrijk, K., van Ginkel, D. J., Versteeg, G. A. A., Grundeken, M. J., Claessen, B. E. P. M., Tonino, P. A. L., Schotborgh, C. E., Meuwissen, M., van Houwelingen, G. K., Wykrzykowska, J. J., Amoroso, G., Vossenberg, T. N., Vriesendorp, P. A., van Royen, N., Berg, J. M. T., Tijssen, J. G. P., ... PRO TAVI Trial Investigators (2026). Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial. Lancet, 407(10537), 1429-1438. https://doi.org/10.1016/S0140-6736(26)00308-9

Franssen, I. S., Jong, M. J. D., Vievermans, A., Stroo, J. F., Henskens, Y. M. C., Spronk, H., Janssen, D. J. A., Braeken, D., van Kuijk, S. M. J., Winckers, K., & Magdelijns, F. J. H. (2026). Adequacy of Direct Oral Anticoagulant Dosing in Nursing Home Residents: Cross-Sectional Data From the DOAC-FRAIL Study. Journal of the American Medical Directors Association, 27(4), Article 106082. https://doi.org/10.1016/j.jamda.2025.106082

Gorog, D. A., ten Berg, J. M., Campo, G., Geisler, T., Gigante, B., Grove, E. L., Halvorsen, S., Huber, K., Jeong, Y.-H., Lip, G. Y. H., Navarese, E. P., Rubboli, A., Siller Matula, J. M., Storey, R. F., Valgimigli, M., Vandenbriele, C., Vilahur, G., Ahrens, I., & Ferreiro, J. L. (2026). Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. European Heart Journal: Acute Cardiovascular Care, 15(4), 337-363. https://doi.org/10.1093/ehjacc/zuag021

Versteeg, G. A. A., Rooijakkers, M. J. P., Hemelrijk, K. I., Vlaar, P. J., Overduin, D. C., van Wely, M. H., Aarts, H. M., van Ginkel, D., Stens, N. A., van Nunen, L. X., van Geuns, R. J., van Garsse, L. A. F. M., Geuzebroek, G. S. C., Verkroost, M. W. A., Cetinyurek-yavuz, A., Heijmen, R. H., Thijssen, D. H. J., ten Berg, J. M., Tonino, P. A. L., ... van Royen, N. (2026). Extremity Function After Transfemoral Transcatheter Aortic Valve Implantation: A TAVI XS Sub-Study. Catheterization and Cardiovascular interventions, 107(5), 1293-1302. https://doi.org/10.1002/ccd.70470